PARP Universal Chemiluminescent Assay Kit


The PARP Universal Chemiluminescent Assay Kit is ideal for the in vitro screening of candidate PARP-1 inhibitors and determination of IC50 values.

Contract Services are also available.

Available Size(s): 96 tests Catalog Number: 4676-096-K Category:


This ELISA based assay detects biotinylated poly (ADP-ribose) deposited by PARP-1 onto immobilized histones in a 96-well format. The addition of Strep-HRP (biotin-binding protein) and a chemiluminescent HRP substrate yields relative light units (RLU) that correlates with PARP-1 activity.


  • Chemiluminescent readout
  • 96 strip-well format
  • Sensitive – detects 10 mU PARP /well
  • Assay Time ~3 hrs

For the in vitro screening of candidate PARP-1 inhibitors and determination of IC50 values.



Material Safety Data Sheet(s)

msds_4671-096-02 20X PARP Buffer

msds_4671-096-03 10X PARP Cocktail

msds_4671-096-06 10X Activated DNA

msds_4668-050-01 PARP HSA Enzyme

msds_4667-50-03 3-Aminobenzamide

msds_4671-096-04 10X Strep-Diluent

4678-096-P Safety Data Sheets are not provided for “articles” defined as a manufactured item other than a fluid or particle.

msds_4800-30-06 Strep-HRP

msds_4675-096-01 PARP PeroxyGlowA

msds_4675-096-02 PARP PeroxyGlowB

Catalog # 4676-096-K includes :
Catalog Number Description Qty
4667-50-03 3-Aminobenzamide 1
4668-050-01 Human PARP 1 Enzyme, HSA 1
4671-096-02 20X PARP Buffer 2
4671-096-03 10X PARP Cocktail 1
4671-096-06 10X Activated DNA 1
4671-096-04 10X Strep-Diluent 1
4675-096-01 PeroxyGlow™ A 1
4675-096-02 PeroxyGlow™ B 1
4678-096-P Histone-Coated White Strip Well Plate 1
4800-30-06 Strep-HRP 1

Role for DNA Damage Signaling in Pulmonary Arterial Hypertension
Meloche, J., Pflieger, A., Vaillancourt, M., Paulin, R., Potus, F., Zervopoulos, S., Graydon, C., Courboulin, A., Breuils-Bonnet, S., Tremblay, E., Couture, C., Michelakis, E.D.,
Circulation, Feb 2014; 129: 786 – 797

YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors
Gregory C. Stachelek, Elizabeth Peterson-Roth, Yanfeng Liu, Rafael J. Fernandez, III, Luke R.G. Pike, Jack M. Qian, Laura Abriola, Denton Hoyer, William Hungerford, Janie Merkel, and Peter M. Glazer
Mol. Cancer Res., Oct 2015; 13: 1389 – 1397.

“Latonduine Analogs Restore F508del–Cystic Fibrosis Transmembrane
Conductance Regulator Trafficking through the Modulation of Poly-ADP
Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity”
“Graeme W. Carlile, Renaud Robert, Elizabeth Matthes, Qi Yang, Roberto Solari, Richard Hatley, Colin M.
Edge, John W. Hanrahan, Raymond Andersen, David Y. Thomas, and Véronique Birault”
Mol. Pharmacol., Jul 2016; 90: 65 – 79.